CUV 0.67% $14.72 clinuvel pharmaceuticals limited

Ann: CUV Appendix 4D Half Year Report, page-37

  1. 615 Posts.
    lightbulb Created with Sketch. 291
    Zero news you say? Are you happy with the anaemic growth in revenue just announced and all the delays? Clinuvel, having failed to secure reimbursement in most EU markets now seem to be pissing the US EPP association off as well. They are charging around $1000 per day! For many the option of generics or competition cannot come soon enough. Clinuvel are an ethical, humble company, with an office in Monaco FFS! Are you also aware that the current chairman has just been relieved of his director role at the company he founded and still owns 70% of, due to significant governance concerns. He is not up to the standard of the Dutch bourse according to his fellow independent directors. NO critical thinking investor will come anywhere near Clinuvel until he is removed from the role of chairman. It makes Capital Group's move seem very savvy when they sold their entire holding of around 3% soon after the Chairmans first hateful address to shareholders (may be no connection). Will our "independent" directors do their job and act to rid Clinuvel of this stain?

    At least we have the promised launch of the sunscreen on Wednesday to look forward to. That's going to be a real winner!
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.72
Change
-0.100(0.67%)
Mkt cap ! $737.1M
Open High Low Value Volume
$14.80 $14.97 $14.60 $600.3K 40.64K

Buyers (Bids)

No. Vol. Price($)
2 324 $14.69
 

Sellers (Offers)

Price($) Vol. No.
$14.75 100 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.